SCOPUS 정보 검색 플랫폼

Volumn 31, Issue 2-3, 2001, Pages 267-270

Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine

(9) De Pas, Tommaso a De Braud, Filippo a Mandalà, Mario a Curigliano, Giuseppe a Catania, Chiara a Ferretti, Gianluigi a Sozzi, Pietro b Solli, Piergiorgio a Goldhirsch, Aron a

a EUROPEAN INSTITUTE OF ONCOLOGY (Italy)

b OSPEDALE DEGLI INFERMI (Italy)

Author keywords

Cisplatin; Lung cancer; Second line chemotherapy; Vinorelbine

Indexed keywords

CISPLATIN; DEXAMETHASONE; GEMCITABINE; NAVELBINE; ONDANSETRON; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; NAUSEA AND VOMITING; NEUROTOXICITY; PRIORITY JOURNAL; RELAPSE; SECOND LINE CHEMOTHERAPY;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; SURVIVAL ANALYSIS; VINBLASTINE;

EID: 0035144916 PISSN: 01695002 EISSN: None Source Type: Journal
DOI: 10.1016/S0169-5002(00)00176-8 Document Type: Article

Times cited : (20)

References (12)

1
- 0006303185
- Non Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: meta-analysis using updated data on individual patients from 52 randomized clinical trials, BMJ 1995; 311:899-909.

2
- 0028154069
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non small cell lung cancer: results of a European multicenter trial including 612 patients
- (1994) J. Clin. Oncol. , vol.12 , pp. 360-367
- Le Chevalier, T.¹ Brisgand, D.² Douillar, J.V.³

3
- 0031861215
- Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non small cell lung cancer: a Southwest Oncology Group Study
- (1998) J. Clin. Oncol. , vol.16 , pp. 2459-2465
- Wozniak, A.J.¹ Crowley, J.J.² Balcerzak, S.P.³

4
- 0032191525
- Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer
- (1998) Lung Cancer , vol.22 , Issue.1 , pp. 31-38
- Martoni, A.¹ Guaraldi, M.² Piana, E.³

5
- 0027952504
- Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial
- (1994) Ann. Oncol. , vol.5 , Issue.1 , pp. 37-42
- Depierre, A.¹ Chastang, C.² Quoix, E.³

6
- 0006360550
- de Braud F, De Pas T, Sessa C, et al. Dose-finding phase I study with weekly Taxol and Gemcitabine in chemo-naive patients with advanced non-small cell lung cancer, Proc Am Soc Clin Oncol 1999 (Abstr 1932).

7
- 0028944053
- Phase II study of Docetaxel for advanced or metastatic platinum-refractory non-small cell lung cancer
- (1995) J. Clin. Oncol. , vol.13 , pp. 645-651
- Fossella, F.V.¹ Lee, J.S.² Shin, D.M.³

8
- 0006359778
- World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48. Geneva, Switzerland: World Health Organization, 1979.

9
- 0031828107
- Single agents in the second-line treatment of non-small cell lung cancer
- (1998) Semin. Oncol. , vol.25 , Issue.3 SUPPL. 8 , pp. 10-14
- Belani, C.P.¹

10
- 0006267871
- Georgoulias V, Kourousis C, Kakolyris S, et al. Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: a preliminary report on an active regimen, Semin Oncol 1997; 24(4 Suppl 12):S12-61-S12-66.

11
- 0026708941
- Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer
- (1992) Cancer Chemother. Pharmacol. , vol.30 , Issue.3 , pp. 212-214
- Gridelli, C.¹ Airoma, G.² Incoronato, P.³

12
- 0033159088
- Paclitaxel combined with cis-platin as second-line treatment in patients with advanced non-small cell lung cancers refractory to cis-platin
- (1999) Oncol. Rep. , vol.6 , Issue.4 , pp. 797-800
- Stathopoulos, G.P.¹ Rigatos, S.² Malamos, N.A.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.